Fischer, Jessica
Hans, Didier
Lamy, Olivier
Marques-Vidal, Pedro
Vollenweider, Peter
Aubry-Rozier, Bérengère http://orcid.org/0000-0002-5732-9734
Funding for this research was provided by:
FNS Project Number (32473B_156978)
Article History
Received: 12 December 2019
Accepted: 27 February 2020
First Online: 5 March 2020
Ethics approval and consent to participate
: The institutional Ethics Committee of the University of Lausanne, which afterwards became the Ethics Commission of Canton Vaud (ExternalRef removed), approved both the CoLaus/PsyCoLaus study and the OsteoLaus study. The studies were performed in accordance with the Helsinki declaration and its former amendments, and following applicable Swiss legislation. All participants gave their signed informed consent before entering the study.
: Not applicable.
: Didier Hans holds stock in the Medimaps Group, makers of trabecular bone score software. Bérengère Aubry-Rozier, Jessica Fischer, Pedro Marques-Vidal, Peter Vollenweider and Olivier Lamy state that they have no conflicts of interest.